How Hauser was paid
$1.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Total |
|---|---|---|---|---|
| Brad HauserChief Executive Officer and President | $356,250 | $1,103,961 | $202,350 | $1,662,561 |
| Lori BissonExecutive Vice Chairman | $210,000 | $355,285 | $93,813 | $659,098 |
| Dr. Robert SchwartzFormer Chief Executive Officer and current Chief Medical Officer | $100,000 | $247,861 | $33,250 | $381,111 |
| Landy TothChief Technology Officer | $147,917 | $165,241 | — | $313,158 |
| Trent SmithChief Financial Officer | $295,000 | $214,831 | $108,300 | $618,131 |
| Walter KlempExecutive Chair | $160,417 | $165,241 | — | $325,658 |
What changed and why
- $1.66M$1.66 million was Brad Hauser’s 2025 total compensation, including $1.10 million in option awards.
- 95%95% of potential bonuses was awarded to Ms. Bisson, Dr. Schwartz, Mr. Smith and Mr. Hauser.
- $450K$450,000 was Hauser’s annual base salary for fiscal 2025, increasing to $468,000 for fiscal 2026.
- 20%20% additional bonus opportunity was available through stretch goals.
- $50,000$50,000 will be the fiscal 2026 base salary for Schwartz, Toth and Klemp after voluntary reductions.
Other Autonomix Medical proxy statements
- 2026 proxy statement
Brad Hauser paid $670,176 (-60% on the year).
Filed Sep 14, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.